Innate Pharma (IPHA) Q3 2024 Earnings

12SepConfirmed
Q3 2023
Q1 2024
Q1 2024
Q3 2024
-0.45
-0.3
-0.15
0

Details

Expected EPS
-0.2999136
Actual EPS
-0.3320472
Surprise EPS
-0.03
Surprise Percent
+10.71%

Description

Innate Pharma (IPHA) has reported earnings of -0.3320472 per share for Q3 2024.

0 Comments

Share your thoughts